Crisaborole May Be Most Effective for Childhood AD
Crisaborole 2% may be more effective than pimecrolimus 1% or tacrolimus 0.03% in patients aged 2 and older with mild-to-moderate AD, according to an unanchored matching-adjusted indirect comparison (MAIC) published in...
Read More